GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Proteins from volcano plot which had notable increases or decreases listed in order of greatest to least significance (adjusted p-values). by Eiman Y. Ibrahim (10731078)

Tissue-specific profiling of the photoreceptor nuclear transcriptome reveals significant changes in early and late aging. by Juan Jauregui-Lozano (12024868)

Top 20 genes with significantly increased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

The expression of miR-122 is decreased as liver fibrosis progressed. by Young Chang (3666829)

Subjects:

Affected cats have significantly increased astrocyte density within the grey matter. by Emily C. Graff (9745447)

“…(<b>F-J</b>) Olig-2 staining indicates no significant change in the density of oligodendrocytes in grey matter, though an insignificant decrease of ~30% was noted in white matter. …”

Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period. by Faran Sabeti (6166766)

“…<p>The only diabetic (non-DMO) person with significant thickness changes was mf87171 (row I). Rows A, B, D and possibly G show that increasing OFA sensitivity (OFA Sens) is associated with decreasing retinal thickness (cf. …”

Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

AD progression drives global perturbations in the microbiota. by Francesco Favero (236209)

Subjects:

Pathway analysis using GRB2, a significantly connected and downregulated protein as the focus. by Eiman Y. Ibrahim (10731078)

List of the proteins that increased or decreased significantly with the progression of liver fibrosis. by Kumiko Shirai (13014884)

“…<p>List of the proteins that increased or decreased significantly with the progression of liver fibrosis.…”

Number and percentage of AE patients with detectable Em2+ antibodies at different visits and significance level in binominal test. by Beate Grüner (301524)

Subjects:

Logistic regression models with variables associated with progressive or cured AE clinical status. by Beate Grüner (301524)

Subjects:

Alveolar echinococcus (AE) patients staged into groups with progressive, with stable and cured disease. by Beate Grüner (301524)

Subjects:

Results of significant p-values (p<0.05) for the Chi-square test between the Moments (M) and the categorical variables. by Maria João Feio (11169654)

Subjects:

Changes of refractive error, axial length, and questionnaire before and after coronavirus disease 2019 according to children’s age. by Hae Ri Yum (2600932)

Subjects:

Comparisons of the changes of refractive error and axial length between pre- and post-coronavirus disease in the 0.05% atropine, 0.025% atropine, and 0.01% atropine groups. by Hae Ri Yum (2600932)

Subjects:

Comparisons of the changes of refractive error and axial length between pre- and post-coronavirus disease 2019 in 5–7, 8–10, and 11–15 years old groups. by Hae Ri Yum (2600932)

Subjects:

Change in laryngeal measures with disease duration and UPDRS part III scores. by Andrew Ma (4532494)

Subjects:

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)